The firm expects Monster’s revenue to grow 5.5% in 2025, led by high-single-digit gains overseas and a rebound in the U.S. market helped by product innovation and steady distribution. Sales velocity, ...

VIENNA/DUBAI (Reuters) -The U.N. nuclear watchdog’s board of governors declared Iran in breach of its non-proliferation obligations on Thursday and it announced counter-measures, as an Iranian ...

The decision places TD Bank among a small group of companies under formal observation by the fund, which holds a 1.05% stake in the Canadian lender as of year-end 2024. Under the fund’s ethical ...

Investing.com - U.S. producer prices returned to growth on a monthly basis in May following an increase in final demand services costs, with demand for travelers’ accommodations ...

While Joby reaffirmed plans to begin pilot testing in Dubai by mid-2025 and start carrying passengers in the region in the first half of 2026, Cantor flagged delays in U.S. certification. The firm ...

The upgrade follows Datadog’s DASH user conference in New York, where Wolfe analysts said customer feedback and new product announcements pointed to improving sentiment. Wolfe had downgraded the stock ...

The potential weakening of geopolitical alignment between the US and its allies undermines foreign capital inflows to the United States, according to Deutsche Bank. The bank noted that the AUKUS ...

Since then, Russia and Ukraine have swapped dozens of prisoners of war, focusing on under-25s and the severely wounded and sick. There are hopes they could build into some of the biggest exchanges in ...

Deletion is one of the most important remedies for violations of privacy,” Palantir wrote, adding that “we cannot stress enough the importance of holding organizations that process Americans’ most ...

The ADP upgrade follows improved regulatory signals and a strategic refocus on its Paris assets. Barclays said political instability remains, but state ownership may shield ADP from further financial ...

While healthtech has seen challenges, UBS sees "significant catch-up potential, and generative A.I. progress should act as another catalyst," noting AstraZeneca (NASDAQ: AZN) as a top gainer. Alcon ...